SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060976
Filing Date
2013-11-13
Accepted
2013-11-13 15:47:55
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v359601_10q.htm 10-Q 738564
2 EXHIBIT 31.1 v359601_ex31-1.htm EX-31.1 11171
3 EXHIBIT 31.2 v359601_ex31-2.htm EX-31.2 11339
4 EXHIBIT 32.1 v359601_ex32-1.htm EX-32.1 5211
5 EXHIBIT 32.2 v359601_ex32-2.htm EX-32.2 4941
  Complete submission text file 0001144204-13-060976.txt   3713416

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20130930.xml EX-101.INS 445854
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20130930.xsd EX-101.SCH 35508
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20130930_cal.xml EX-101.CAL 25505
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20130930_def.xml EX-101.DEF 159383
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20130930_lab.xml EX-101.LAB 242050
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20130930_pre.xml EX-101.PRE 190316
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 131214472
SIC: 2834 Pharmaceutical Preparations